Disease The intractable diseases designated by MHLW, Japan
Diseases : 348 - Clinical trials : 39,610 / Drugs : 18,765 - ( DrugBank : 2,435 ) / Drug target genes : 703 - Drug target pathways : 305
ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients (FY2023) |
---|---|---|---|---|---|
34 | Neurofibromatosis [Skin] 💬 "Neurofibromatosis type 1", "NF1", "Recklinghausen disease", "Neurofibromatosis type 2", "NF2" | 165 165 trials | 46 / 102 / 13 / 6 💬 | 189 189 drugs [ 83 83 drugs ] | 93 93 genes 209 pathways | 4167 4,167 patientsAge distribution
![]() |
35 | Pemphigus [Skin] 💬 | 120 120 trials | 10 / 32 / 50 / 6 💬 | 109 109 drugs [ 40 40 drugs ] | 28 28 genes 167 pathways | 3186 3,186 patientsAge distribution
![]() |
36 | Epidermolysis bullosa [Skin] 💬 "Kindler syndrome" | 183 183 trials | 51 / 104 / 52 / 2 💬 | 159 159 drugs [ 51 51 drugs ] | 69 69 genes 147 pathways | 289 289 patientsAge distribution
![]() |
37 | Generalised pustular psoriasis [Skin] 💬 "GPP", "Pustular psoriasis", "Herpetic impetigo" | 93 93 trials | 3 / 30 / 44 / 5 💬 | 50 50 drugs [ 21 21 drugs ] | 21 21 genes 99 pathways | 2235 2,235 patientsAge distribution
![]() |
38 | Stevens-Johnson syndrome [Skin] 💬 "SJS", "Mucocutaneous ocular syndrome" | 19 19 trials | 7 / 10 / 3 / 2 💬 | 25 25 drugs [ 10 10 drugs ] | 14 14 genes 98 pathways | 185 185 patientsAge distribution
![]() |
39 | Toxic epidermal necrolysis [Skin] 💬 "Toxic epidermal necrosis", "TEN" | 15 15 trials | 2 / 3 / 0 / 1 💬 | 16 16 drugs [ 9 9 drugs ] | 10 10 genes 99 pathways | 78 78 patientsAge distribution
![]() |
159 | Xeroderma pigmentosum [Skin] 💬 "XP" | 11 11 trials | 1 / 8 / 1 / 0 💬 | 11 11 drugs [ 5 5 drugs ] | 5 5 genes 16 pathways | 87 87 patientsAge distribution
![]() |
160 | Congenital ichthyosis [Skin] 💬 "Keratinopathic ichthyosis", "Epidermolytic ichthyosis", "Superficial epidermolytic ichthyosis", "Harlequin ichthyosis", "Autosomal recessive congenital ichthyosis", "Congenital Ichthyosiform Erythroderma", "Foliate ichthyosis", "Ichthyosis syndrome", "Netherton syndrome", "Sjogren-Larsson syndrome", "Sjögren-Larsson syndrome", "Keratitis-ichtyosis-deafness syndrome", "KID syndrome", "Dorfman-Chanarin syndrome", "Neutral lipid storage disease", "NLSD", "Multiple sulfatase deficiency", "Austin disease", "Recessive X-linked ichthyosis", "RXLI", "X-linked recessive ichthyosis", "Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature", "IBID", "Trichothiodystrophy", "Follicular ichthyosis", "Congenital hemidysplasia, ichthyosiform erythroderma or nevus, and limb defects syndrome", "CHILD syndrome", "Conradi-Hunermann-Happle syndrome", "Conradi-Hünermann-Happle syndrome", "CHHS" | 57 57 trials | 16 / 25 / 13 / 2 💬 | 68 68 drugs [ 25 25 drugs ] | 21 21 genes 141 pathways | 100 100 patientsAge distribution
![]() |
161 | Familial benign chronic pemphigus [Skin] 💬 "Benign familial pemphigus", "Hailey-Hailey disease" | 6 6 trials | 2 / 3 / 0 / 0 💬 | 6 6 drugs [ 3 3 drugs ] | 2 2 genes 29 pathways | 79 79 patientsAge distribution
![]() |
162 | Pemphigoid [Skin] 💬 | 128 128 trials | 3 / 43 / 45 / 9 💬 | 108 108 drugs [ 49 49 drugs ] | 35 35 genes 143 pathways | 4086 4,086 patientsAge distribution
![]() |
163 | Idiopathic pure sudomotor failure [Skin] 💬 "Idiopathic acquired systemic anhidrosis", "Acquired idiopathic generalized anhidrosis", "AIGA", "Idiopathic segmental anhidrosis", "Idiopathic pure sudomotor failure", "IPSF", "Sweat gland failure" | 0 - | 0 - | 0 - | 655 655 patientsAge distribution
![]() |
166 | Pseudoxanthoma elasticum [Skin] 💬 "PXE" | 19 19 trials | 4 / 14 / 3 / 1 💬 | 21 21 drugs [ 7 7 drugs ] | 5 5 genes 26 pathways | 143 143 patientsAge distribution
![]() |